{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T07:34:27Z","timestamp":1777275267078,"version":"3.51.4"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jccjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jcrc.2018.03.015","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T20:22:36Z","timestamp":1521404556000},"page":"184-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["The critically ill patient with tuberculosis in intensive care: Clinical presentations, management and infection control"],"prefix":"10.1016","volume":"45","author":[{"given":"Akaninyene","family":"Otu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madiha","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed M.","family":"Mukhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Kwizera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9424-6551","authenticated-orcid":false,"given":"Simon","family":"Tiberi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Macrae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alimudin","family":"Zumla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin W.","family":"D\u00fcnser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mervyn","family":"Mer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2018.03.015_bb0005","author":"World Health Organization"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2334-14-5","article-title":"Tuberculosis mortality: patient characteristics and causes","volume":"14","author":"Lin","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0015","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJMra1200894","article-title":"Tuberculosis","volume":"368","author":"Zumla","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0020","first-page":"279","article-title":"Tuberculosis deaths in a tertiary hospital in Goiania, Brazil: a descriptive study","volume":"4","author":"Tavares","year":"2013","journal-title":"Infez Med"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0025","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1183\/09031936.06.00088105","article-title":"Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care","volume":"27","author":"Erbes","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0030","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1097\/CCM.0000000000000541","article-title":"Simplified severe sepsis protocol: a randomized controlled trial of modified early goal-directed therapy in Zambia","volume":"42","author":"Andrews","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0035","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.2017.10913","article-title":"Effect of an early resuscitation protocol on in-hospital mortality among adults with sepsis and hypotension: a randomized clinical trial","volume":"318","author":"Andrews","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/0a53f994-bfe2-45db-9dbb-97fdfea023c5","article-title":"Mycobacterium tuberculosis bacteremia in a cohort of HIV-infected patients hospitalized with severe sepsis in Uganda \u2013 high frequency, low clinical sand derivation of a clinical prediction score","volume":"8","author":"Jacob","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0045","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3906\/sag-1408-118","article-title":"Acute tuberculosis in the intensive care unit","volume":"45","author":"Rollas","year":"2015","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0050","doi-asserted-by":"crossref","first-page":"581","DOI":"10.5588\/ijtld.13.0901","article-title":"Tuberculosis in the intensive care unit: a descriptive analysis in a low-burden country","volume":"18","author":"Lanoix","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0055","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2334-10-54","article-title":"Mortality among patients with tuberculosis requiring intensive care: a retrospective cohort study","volume":"10","author":"Silva","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0060","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00006454-199805000-00011","article-title":"Management of children with tuberculosis admitted to a pediatric intensive care unit","volume":"17","author":"Heyns","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/0970-2113.197110","article-title":"Pulmonary tuberculosis \u2013 an emerging risk factor for venous thromboembolism: a case series and review of literature","volume":"34","author":"Gupta","year":"2017","journal-title":"Lung India"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0070","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/cid\/cit780","article-title":"Active tuberculosis and venous thromboembolism: association according to international classification of diseases, ninth revision hospital discharge diagnosis codes","volume":"58","author":"Dentan","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5812\/archcid.13950","article-title":"Incidence of thromboembolism in hospitalized patients with tuberculosis and associated risk factors","volume":"7","author":"Marjani","year":"2012","journal-title":"Arch Clin Infect Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0080","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1046\/j.1365-2141.1996.d01-1722.x","article-title":"Acute phase response and the hypercoagulable state in pulmonary tuberculosis","volume":"93","author":"Robson","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0085","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0140-6736(89)90603-X","article-title":"Venous thromboembolism and rifampicin","volume":"2","author":"White","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0090","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/cc12760","article-title":"Clinical review: tuberculosis on the intensive care unit","volume":"17","author":"Hagan","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0095","first-page":"9535463","article-title":"Severe tuberculosis requiring intensive care: a descriptive analysis","volume":"2017","author":"Duro","year":"2017","journal-title":"Crit Care Res Prac"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0100","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4046\/trd.2016.79.3.158","article-title":"Characteristics of active tuberculosis patients requiring intensive care monitoring and factors affecting mortality","volume":"79","author":"Filiz","year":"2016","journal-title":"Tuber Respir Dis (Seoul)"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1155\/2012\/361292","article-title":"Tuberculosis in the intensive care unit: a retrospective descriptive cohort study with determination of a predictive fatality score","volume":"24","author":"Valade","year":"2012","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0110","first-page":"335","article-title":"Predictive factors for mortality among non-HIV-infected patients with pulmonary tuberculosis and respiratory failure","volume":"13","author":"Lin","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0115","doi-asserted-by":"crossref","first-page":"R207","DOI":"10.1186\/cc11839","article-title":"Empirical use of fluoroquinolones improves the survival of critically ill patients with tuberculosis mimicking severe pneumonia","volume":"16","author":"Tseng","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0120","series-title":"Guidelines for treatment of tuberculosis","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0125","author":"National Institute for Health and Care Excellence"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0130","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1056\/NEJMra1413919","article-title":"Treatment of tuberculosis","volume":"373","author":"Horsburgh","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0135","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1378\/chest.12-1286","article-title":"Mycobacterium tuberculosis septic shock","volume":"144","author":"Kethireddy","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0140","doi-asserted-by":"crossref","first-page":"812","DOI":"10.5858\/arpa.2011-0578-RA","article-title":"Rapid diagnosis of mycobacterium tuberculosis infection and drug susceptibility testing","volume":"137","author":"Wilson","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0145","first-page":"879","article-title":"U.S. Public Health Service Cooperative trial of three rifampicin-isoniazid regimens in treatment of pulmonary tuberculosis","volume":"119","author":"Long","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0150","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/cid\/cis353","article-title":"Meta-analysis of clinical studies supports the pharmacokinetic variability hypothesis for acquired drug resistance and failure of antituberculosis therapy","volume":"55","author":"Pasipanodya","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0155","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ccc.2006.02.011","article-title":"Pharmacokinetic changes in critical illness","volume":"22","author":"Boucher","year":"2006","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0160","doi-asserted-by":"crossref","first-page":"394","DOI":"10.7196\/SAMJ.6344","article-title":"The pharmacokinetics of enteral anti-TB drugs in patients requiring intensive care","volume":"103","author":"Koegelenberg","year":"2013","journal-title":"S Afr Med J"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0165","first-page":"1","article-title":"Therapeutic drug monitoring of antitubercular agents for disseminated mycobacterium tuberculosis during intermittent haemodialysis and continuous venovenous haemofiltration","volume":"2017","author":"Sin","year":"2017","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0170","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/MAT.0000000000000096","article-title":"Insufficient serum levels of anti-TB agents during venovenous extracorporeal membrane oxygenation therapy for acute respiratory distress syndrome in a patient with military tuberculosis","volume":"60","author":"Kim","year":"2014","journal-title":"ASAIO J"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0175","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1164\/rccm.200208-951OC","article-title":"Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine","volume":"167","author":"Weiner","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0180","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0041-3879(84)90079-5","article-title":"The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis","volume":"65","author":"Ellard","year":"1984","journal-title":"Tubercle"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0185","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1473-3099(12)70264-5","article-title":"Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial","volume":"13","author":"Ruslami","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0190","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ijantimicag.2014.12.027","article-title":"Pharmacokinetic\/pharmacodynamics analysis of an intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis","volume":"45","author":"Te Brake","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0195","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1507062","article-title":"Intensified anti-TB therapy in adults with tuberculous meningitis","volume":"374","author":"Heemskerk","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0200","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3343\/alm.2017.37.2.97","article-title":"Recommendations for optimizing tuberculosis treatment: therapeutic drug monitoring, pharmacogenetics, and nutritional status considerations","volume":"37","author":"Choi","year":"2017","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0205","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2165\/00003495-200262150-00001","article-title":"Therapeutic drug monitoring in the treatment of tuberculosis","volume":"62","author":"Peloquin","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0210","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.5588\/ijtld.14.0935","article-title":"Rifampicin-moxifloxacin interaction in tuberculosis treatment: a real-life study","volume":"19","author":"Manika","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0215","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1164\/rccm.201112-2174ED","article-title":"Monitoring for tuberculosis drug hepatotoxicity: moving from opinion to evidence","volume":"185","author":"Saukkonen","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0220","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jceh.2012.12.001","article-title":"Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management","volume":"3","author":"Ramappa","year":"2013","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0225","first-page":"233","article-title":"Corticosteroids for prevention of mortality in people with tuberculosis: a systematic review and meta-analysis","volume":"13","author":"Critchley","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0230","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/cid\/ciw616","article-title":"Effects of corticosteroids on critically ill pulmonary tuberculosis patients with acute respiratory failure: a propensity analysis of mortality","volume":"63","author":"Yang","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0235","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1378\/chest.08-1149","article-title":"Critical illness-related corticosteroid insufficiency","volume":"135","author":"Marik","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0240","first-page":"548","article-title":"Changes in cortisol metabolism following rifampicin therapy","volume":"2","author":"Edwards","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0245","first-page":"127","article-title":"Reversal of subclinical adrenal insufficiency through antituberculosis treatment in TB patients: a longitudinal follow up","volume":"122","author":"Sharma","year":"2005","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0250","first-page":"67","article-title":"Evaluation of pseudoadrenal insufficiency in tuberculosis patients","volume":"6","author":"Tabarsi","year":"2007","journal-title":"Tanaffos"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0255","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00003246-198703000-00008","article-title":"Acute respiratory failure in active tuberculosis","volume":"15","author":"Levy","year":"1987","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0260","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s00134-005-2721-2","article-title":"Experience with ARDS caused by tuberculosis in a respiratory intensive care unit","volume":"31","author":"Agarwal","year":"2005","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0265","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1378\/chest.73.1.37","article-title":"The adult respiratory distress syndrome associated with military tuberculosis","volume":"73","author":"Murray","year":"1978","journal-title":"Chest"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0270","first-page":"E1","article-title":"Acute respiratory distress syndrome with military tuberculosis: a fatal combination","volume":"5","author":"Abi-Fadel","year":"2013","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0275","first-page":"2626","article-title":"Acute respiratory distress syndrome: the Berlin Definition","volume":"307","author":"ARDS Definition Task Force","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0280","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1164\/ajrccm\/151.3_Pt_1.867","article-title":"Tuberculosis as a primary cause of respiratory failure requiring mechanical ventilation","volume":"151","author":"Penner","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0285","doi-asserted-by":"crossref","first-page":"114S","DOI":"10.1378\/chest.124.4_MeetingAbstracts.114S-a","article-title":"Acute respiratory distress syndrome in pulmonary tuberculosis","volume":"124","author":"Banga","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0290","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.2169\/internalmedicine.49.3749","article-title":"Noninvasive ventilation in patients with acute exacerbation of pulmonary tuberculosis sequelae","volume":"49","author":"Aso","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0295","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/00003246-198711000-00005","article-title":"Active tuberculosis in the medical intensive care unit: a 15-year retrospective analysis","volume":"15","author":"Frame","year":"1987","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0300","first-page":"589","article-title":"Role of apache score in predicting mortality in chest ICU","volume":"61","author":"Haidri","year":"2011","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0305","first-page":"182","article-title":"Thoracic surgery for haemoptysis in the context of tuberculosis: what is the best management approach?","volume":"6","author":"Halezeroglu","year":"2014","journal-title":"Thorac Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0310","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/thorax.58.9.814","article-title":"The pulmonary physician in critical care: illustrative case 7: assessment and management of massive haemoptysis","volume":"58","author":"Lordan","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0315","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1010-7940(02)00337-8","article-title":"Massive hemoptysis: what place for medical and surgical management","volume":"22","author":"Jougon","year":"2002","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0320","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/archsurg.133.8.862","article-title":"Role of bronchial artery embolization in the management of hemoptysis","volume":"133","author":"Fernando","year":"1998","journal-title":"Arch Surg"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0325","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1056\/NEJMoa040573","article-title":"Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults","volume":"315","author":"Thwaites","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0330","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/cid\/cir230","article-title":"Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)-associated tuberculous meningitis","volume":"52","author":"Torok","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0335","first-page":"64","article-title":"Predictors of outcome in patients with tuberculous meningitis","volume":"6","author":"Hosoglu","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0340","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2217\/fmb.12.86","article-title":"Tuberculous meningitis in adults: a review of a decade of developments focusing on prognostic factors for outcome","volume":"7","author":"Brancusi","year":"2012","journal-title":"Future Microbiol"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0345","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.amjmed.2008.09.018","article-title":"Acute forms of tuberculosis in adults","volume":"122","author":"Jacob","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0350","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1474-4422(05)70019-3","article-title":"Tuberculous meningitis: many questions, too few answers","volume":"4","author":"Thwaites","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0355","first-page":"34","article-title":"Cerebral tuberculomas \u2013a clinical challenge","volume":"9","author":"Monteiro","year":"2013","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020077","article-title":"Presentation and outcome of tuberculous meningitis in a high HIV prevalence setting","volume":"6","author":"Marais","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0365","first-page":"RA215","article-title":"Pathogenesis, diagnosis, treatment, and outcome aspects of cerebral tuberculosis","volume":"10","author":"Katti","year":"2004","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0370","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1552-6569.2003.tb00185.x","article-title":"Brain CT and MRI findings in 100 consecutive patients with intracranial tuberculoma","volume":"13","author":"Wasay","year":"2003","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0375","first-page":"234","article-title":"Intracranial tuberculomas in patients with tuberculous meningitis: predictors and prognostic significance","volume":"15","author":"Anuradha","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0380","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/clinids\/22.6.982","article-title":"Tuberculous meningitis in adults: review of 48 cases","volume":"22","author":"Verdon","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0385","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1473-3099(12)70264-5","article-title":"Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial","volume":"13","author":"Ruslami","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0390","article-title":"Corticosteroids for managing tuberculous meningitis","volume":"4","author":"Prasad","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0395","doi-asserted-by":"crossref","first-page":"716","DOI":"10.4103\/0028-3886.72178","article-title":"Tuberculous meningitis: the challenges","volume":"58","author":"Murthy","year":"2010","journal-title":"Neurol India"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0400","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jns.2010.03.025","article-title":"Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial","volume":"293","author":"Misra","year":"2010","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0405","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1177\/0883073811398132","article-title":"The role of aspirin in childhood tuberculous meningitis","volume":"26","author":"Schoeman","year":"2011","journal-title":"J Child Neurol"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0410","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1097\/INF.0000000000001285","article-title":"Thalidomide in refractory tuberculomas and pseudoabscesses","volume":"35","author":"Viel-Th\u00e9riault","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0415","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/QCO.0000000000000090","article-title":"Complications of tuberculosis","volume":"27","author":"Shah","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0420","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/qjmed\/hch086","article-title":"Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10years follow-up","volume":"97","author":"Strang","year":"2004","journal-title":"QJM"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0425","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/qjmed\/hcl123","article-title":"Diagnosing tuberculous pericarditis","volume":"99","author":"Reuter","year":"2006","journal-title":"QJM"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0430","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0002-9343(02)01261-5","article-title":"Comparison of polymerase chain reaction with adenosine deaminase activity in pericardial fluid for the diagnosis of tuberculous pericarditis","volume":"113","author":"Lee","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0435","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(88)92415-4","article-title":"Controlled clinical trial of complete open surgical drainage and of prednisolone in treatment of tuberculous pericardial effusion in Transkei","volume":"2","author":"Strang","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0440","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4240\/wjgs.v9.i8.174","article-title":"Abdominal tuberculosis: is there a role for surgery?","volume":"9","author":"Weledji","year":"2017","journal-title":"World J Gastrointest Surg"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0445","first-page":"NC07","article-title":"Abdominal tuberculosis with an acute abdomen: our clinical experience","volume":"8","author":"Mukhopadhyay","year":"2014","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0450","first-page":"324","article-title":"Abdominal tuberculosis. Experiences with 300 cases","volume":"67","author":"Bhansali","year":"1977","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0455","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/00015458.2009.11680374","article-title":"Peritoneal tuberculosis in laparoscopic era","volume":"109","author":"Tarcoveanu","year":"2009","journal-title":"Acta Chir Belg"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0460","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/014107688607900307","article-title":"Abdominal tuberculosis: still a problem today","volume":"79","author":"Wells","year":"1986","journal-title":"R Soc Med"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0465","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1055\/s-2007-1001274","article-title":"Endoscopic balloon dilation of ileal stricture due to tuberculosis","volume":"30","author":"Bhasin","year":"1998","journal-title":"Endoscopy"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0470","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.otohns.2007.04.002","article-title":"Laryngeal tuberculosis: a review of 26 cases","volume":"137","author":"Wang","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0475","first-page":"5","article-title":"Musculoskeletal tuberculosis","volume":"2017","author":"Leonard","year":"2017","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0480","first-page":"703","article-title":"Challenges in the diagnosis & treatment of military tuberculosis","volume":"135","author":"Sharma","year":"2012","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0485","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jctube.2016.03.003","article-title":"Miliary tuberculosis: a new look at an old foe","volume":"3","author":"Sharma","year":"2016","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002464","article-title":"Tuberculosis and HIV co-infection","volume":"8","author":"Pawlowski","year":"2012","journal-title":"PLoS Pathog"},{"issue":"Suppl. 3","key":"10.1016\/j.jcrc.2018.03.015_bb0495","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1086\/651492","article-title":"HIV infection-associated tuberculosis: the epidemiology and the response","volume":"50","author":"Getahun","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0500","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0905848","article-title":"Timing of initiation of antiretroviral drugs during tuberculosis therapy","volume":"362","author":"Abdool Karim","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0505","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJMoa1013911","article-title":"Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis","volume":"365","author":"Blanc","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0510","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3851\/IMP1455","article-title":"Effectiveness and safety of antiretrovirals with rifampicin: crucial issues for high-burden countries","volume":"14","author":"Maartens","year":"2009","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0515","first-page":"6","article-title":"Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa","volume":"13","author":"Harries","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0520","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jctube.2016.03.002","article-title":"Tuberculosis \u2013 immune reconstitution inflammatory syndrome","volume":"3","author":"Sandro Vento","year":"2016","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0525","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/sti.79.4.337","article-title":"Adult respiratory distress syndrome as a severe immune reconstitution disease following the commencement of highly active antiretroviral therapy","volume":"79","author":"Goldsack","year":"2003","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0530","first-page":"1290","article-title":"Paradoxical response during anti-tuberculosis treatment in HIV-negative patients with pulmonary tuberculosis","volume":"11","author":"Cheng","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0535","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1086\/425742","article-title":"Determinants of immune reconstitution inflammatory syndrome in HIV type 1- infected patients with tuberculosis after initiation of antiretroviral therapy","volume":"39","author":"Breton","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0540","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1468-1293.2000.00012.x","article-title":"Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy","volume":"1","author":"French","year":"2000","journal-title":"HIV Med"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0545","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/QAD.0b013e32833dfc68","article-title":"Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome","volume":"24","author":"Meintjes","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0550","doi-asserted-by":"crossref","first-page":"476","DOI":"10.4103\/0019-5154.87114","article-title":"The immune reconstitution inflammatory syndrome","volume":"56","author":"Bosamiya","year":"2011","journal-title":"Indian J Dermatol"},{"issue":"Suppl. 2","key":"10.1016\/j.jcrc.2018.03.015_bb0555","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.ajic.2007.10.007","article-title":"2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings","volume":"35","author":"Siegel","year":"2007","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0560","series-title":"WHO policy on TB infection control in health-care facilities, congregate settings and households","author":"Scano","year":"2009"},{"issue":"54","key":"10.1016\/j.jcrc.2018.03.015_bb0565","first-page":"1","article-title":"Guidelines for preventing the transmission of mycobacterium tuberculosis in health-care settings","volume":"2005","author":"Jensen","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jcrc.2018.03.015_bb0570","first-page":"1","article-title":"Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC)","volume":"52","author":"Sehulster","year":"2003","journal-title":"MMWR Recomm Rep"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944118301400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944118301400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T09:28:01Z","timestamp":1660642081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944118301400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":114,"alternative-id":["S0883944118301400"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2018.03.015","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The critically ill patient with tuberculosis in intensive care: Clinical presentations, management and infection control","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2018.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}